Chemoinformaics analysis of 9H-PYRIDO[3,4-B]INDOL-1-YLMETHANOL
| Molecular Weight | 198.225 | nRot | 1 |
| Heavy Atom Molecular Weight | 188.145 | nRig | 2 |
| Exact Molecular Weight | 198.079 | nRing | 3 |
| Solubility: LogS | -6.598 | nHRing | 2 |
| Solubility: LogP | 9.494 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 15 |
| nHA | 2 | APOL | 29.7099 |
| nHD | 2 | BPOL | 11.7421 |
| QED | 0.163 |
| Synth | 2.084 |
| Natural Product Likeliness | 0.669 |
| NR-PPAR-gamma | 0.972 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -5.099 |
| MDCK | 0.0000149 |
| BBB | 0.016 |
| PPB | 0.992258 |
| VDSS | 1.551 |
| FU | 0.00918747 |
| CYP1A2-inh | 0.158 |
| CYP1A2-sub | 0.156 |
| CYP2c19-inh | 0.239 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.087 |
| CYP2c9-sub | 0.994 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.038 |
| CYP3a4-inh | 0.102 |
| CYP3a4-sub | 0.008 |
| CL | 2.711 |
| T12 | 0.24 |
| hERG | 0.125 |
| Ames | 0.004 |
| ROA | 0.009 |
| SkinSen | 0.965 |
| Carcinogencity | 0.05 |
| EI | 0.926 |
| Respiratory | 0.597 |
| NR-Aromatase | 0.219 |
| Antiviral | No |
| Prediction | 0.61306 |